alpha-Neoendorphin-like immunoreactivity in medullary carcinoma of the thyroid. 1987

M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo

alpha-Neoendorphin-like immunoreactivities (alpha-NE-IR) were demonstrated in tissues from three patients with medullary carcinoma of the thyroid (MCT). A large amount of alpha-NE-IR was detected in the extracts of primary tumors and metastatic lymphatic tissues by a highly sensitive and specific radioimmunoassay (RIA). Gel filtration analyses showed two different molecular-weight forms of the alpha-NE-IR: One eluted at the void fraction and the other at the position of [125I]-alpha-NE on Sephadex (Pharmacia Fine Chemical, Uppsala, Sweden) G-50 chromatography. Immunohistochemical examination revealed the presence of alpha-NE-IR in the C-cell carcinoma. These data presumably reflect that alpha-NE, the opioid peptide derived from preproenkephalin B, is synthesized in the MCT.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011498 Protein Precursors Precursors, Protein
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
November 1985, American journal of clinical pathology,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
November 1980, Cancer research,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
April 1983, Journal of submicroscopic cytology,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
June 1993, Journal of neuroendocrinology,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
June 1984, Cancer,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
November 1980, Endocrinology,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
July 1994, Cancer,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
September 1995, Human pathology,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
January 1982, Nihon rinsho. Japanese journal of clinical medicine,
M Ohashi, and T Yanase, and N Fujio, and H Ibayashi, and M Kinjo, and H Matsuo
September 1987, Laboratory investigation; a journal of technical methods and pathology,
Copied contents to your clipboard!